FY’24 results showcase growth potential with 12% IRR, strategic acquisitions, and undervalued stock. Read more on TMO stock ...

We recently published a list of the 10 Best Strong Buy Stocks To Buy Right Now. In this article, we are going to take a look ...

Thermo Fisher Scientific CIO Ryan Snyder believes business strategy and tech strategy should be woven together and that data ...

Thermo Fisher Scientific (NYSE:TMO – Get Free Report) had its price target reduced by research analysts at Citigroup from ...

Explore Thermo Fisher Scientific Inc.'s valuation, modest growth challenges, and recent M&A moves. Click for my updated look ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

Once the transaction closes, Solventum’s Purification & Filtration business will become part of Thermo Fisher's Life Sciences Solutions segment. Solventum’s Purification & Filtration ...

Citi lowered the firm’s price target on Thermo Fisher (TMO) to $570 from $650 and keeps a Neutral rating on the shares. The firm updated models in the life science tools and diagnostics group post the ...

The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, according to Marc N. Casper, chairman, president, and CEO of Thermo Fisher.

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue ...

Thermo Fisher Scientific agreed to acquire Solventum's purification and filtration business for $4.1 billion in cash, confirming a report first made in The Wall Street Journal.

The deal will join the Solventum group with Thermo Fisher’s bioproduction business ... business sits within the company’s life sciences solutions segment. Prior to the Solventum deal, Thermo ...